Ramos Filho Ramon, Carneiro Megmar A S, Teles Sheila A, Dias Márcia A, Cardoso Divina D P, Lampe Elisabeth, Yoshida Clara F T, Martins Regina M B
Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Caixa Postal 131, 74605-050 Goiânia, GO, Brazil.
Mem Inst Oswaldo Cruz. 2004 Oct;99(6):639-43. doi: 10.1590/s0074-02762004000600019. Epub 2004 Nov 18.
In order to investigate the prevalence of GB virus C (GBV-C)/hepatitis G virus (HGV) infection in dialysis patients and kidney transplant recipients in Central Brazil and also to analyze the virus genotypes distribution, a total of 123 patients including 98 on hemodialysis, 13 on continuous ambulatory peritoneal dialysis treatment, and 12 who received kidney transplantation were interviewed in one unit of dialysis treatment in Goiania city. Blood samples were collected and serum samples tested for GBV-C/HGV RNA by polymerase chain reaction. Genotypes were determined by restriction fragment length polymorphism (RFLP) analysis. Eighteen samples were GBV-C/HGV RNA-positive, resulting in an overall prevalence of 14.6% (95% CI: 9.2-21.7). A high positivity for GBV-C/HGV RNA was observed in patients who had received kidney transplant (16.7%), followed by those on hemodialysis (15.3%), and peritoneal dialysis (7.7%). RFLP analysis revealed the presence of genotypes 1, 2, and 3 of GBV-C/HGV; more precisely, 9 (50%) samples were found belonging to the 2b subtype, 4 (22%) to the 2a subtype, 3 (17%) to genotype 1, and 2 (11%) to genotype 3. The present data indicate an intermediate prevalence of GBV-C/HGV infection among dialysis patients and kidney transplant recipients in Central Brazil. Genotype 2 (subtype 2b) seems to be the most prevalent GBV-C/HGV genotype in our region.
为调查巴西中部透析患者和肾移植受者中GB病毒C(GBV-C)/庚型肝炎病毒(HGV)感染的流行情况,并分析病毒基因型分布,在戈亚尼亚市的一个透析治疗单位对123名患者进行了访谈,其中包括98名接受血液透析的患者、13名接受持续性非卧床腹膜透析治疗的患者以及12名接受肾移植的患者。采集血样,通过聚合酶链反应检测血清样本中的GBV-C/HGV RNA。通过限制性片段长度多态性(RFLP)分析确定基因型。18份样本GBV-C/HGV RNA呈阳性,总体流行率为14.6%(95%可信区间:9.2-21.7)。在接受肾移植的患者中观察到GBV-C/HGV RNA的高阳性率(16.7%),其次是接受血液透析的患者(15.3%)和腹膜透析患者(7.7%)。RFLP分析显示存在GBV-C/HGV的基因型1、2和3;更确切地说,发现9份(50%)样本属于2b亚型,4份(22%)属于2a亚型,3份(17%)属于基因型1,2份(11%)属于基因型3。目前的数据表明巴西中部透析患者和肾移植受者中GBV-C/HGV感染的流行率处于中等水平。基因型2(2b亚型)似乎是我们地区最常见的GBV-C/HGV基因型。